ARCHIVES

New Compounds To Treat Gleevec-Resistant CML

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

Environmental Emphasis Urged, Including New Role For Comp Centers NCAB Unenthusiastic

March 21, 1975

In Congress: Conferees Approve 42 billion Increase For NIH Appropriations

October 29, 1999

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983